| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
146 |
123 |
$140K |
| Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg |
36 |
31 |
$25K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
457 |
370 |
$21K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
206 |
172 |
$9K |
| 92134 |
|
598 |
489 |
$9K |
| 92020 |
|
103 |
88 |
$1K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16 |
14 |
$598.77 |